tofacitinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (1)
Phase 4 (1)

Interventional (2)

Shanghai Zhongshan Hospital (1)
University of Colorado, Denver (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadhair thinning

I am/have/hadeczema

I am/have/hadpsoriasis

I am/have/hadskin disease

I am/have/hadantibiotics

I am/have/hadherpes zoster

I am/have/hadatopic dermatitis

I am/have/hadhidradenitis suppurativa

I am/have/hadatopic diathesis

I am/have/hadantibiotic therapy

I am/have/haddermatitis

I am/have/hadvitiligo

I am/have/hadunbalanced translocation

I am/have/hadhidradenitis

I am/have/hadskin disorder

I am/have/haddown syndrome

I am/have/haddisseminated herpes simplex

I am/have/haddermatosis

I am/have/hadantibiotic

I am/have/hadalopecia

added new label for I am/have/had

more

I am looking for

I am looking fortofacitinib

I am looking forantibiotics

I am looking forantimicrobials

I am looking forinterferon

I am looking forantibiotic

I am looking forantimicrobial

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 4
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

The aim of this study is to evaluate and compare the efficacy and safety of tofacitinib and methotrexate based on prednisone therapy in patients with Takayasu arteritis

0 views
19 Feb, 2024

Phase 2
For adults
Recruiting in 10s
Interventional Study
all
Dermatology
Recruiting

Tofacitinib for Immune Skin Conditions in Down Syndrome

The study evaluates the safety and efficacy treatment with Tofacitinib, an FDA-approved drug known to block IFN signaling, in adults with DS and an autoimmune and/or autoinflammatory skin condition.

atopic diathesis

hidradenitis suppurativa

antibiotics

hidradenitis

unbalanced translocation

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.